|PRODUCT NAME||CATALOG #||UNIT||PRICE||QTY||FAVORITES|
|Met Antibody (B-2)||sc-8057||200 µg/ml||$279.00||
|Met Antibody (B-2) AC||sc-8057 AC||500 µg/ml, 25% ag||$366.00||
|Met Antibody (B-2) Alexa Fluor® 488||sc-8057 AF488||200 µg/ml||$314.00||
|Met Antibody (B-2) Alexa Fluor® 647||sc-8057 AF647||200 µg/ml||$314.00||
|Met Antibody (B-2) FITC||sc-8057 FITC||200 µg/ml||$292.00||
|Met Antibody (B-2) HRP||sc-8057 HRP||200 µg/ml||$279.00||
|Met (B-2) Blocking Peptide||sc-8057 P||100 µg/0.5 ml||$61.00||
|Met Antibody (B-2) PE||sc-8057 PE||200 µg/ml||$303.00||
See how others have used Met Antibody (B-2). Click on the entry to view the PubMed entry .
PMID: # 28559994
Zhao, Y. et al. 2017. MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-Met. Am J Transl Res. 9: 2437-2446.
PMID: # 26893768
Hu, HJ. et al. 2016. Curcumin mediates reversion of HGF-induced epithelial-mesenchymal transition via inhibition of c-Met expression in DU145 cells. Oncology letters. 11: 1499-1505.
PMID: # 26728565
Peng, Y. et al. 2016. The autism-associated MET receptor tyrosine kinase engages early neuronal growth mechanism and controls glutamatergic circuits development in the forebrain. Molecular psychiatry.
PMID: # 26177924
Towner, RA. et al. 2015. A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model. BMC cancer. 15: 522.
PMID: # 25744385
Berruti, G. et al. 2015. USP8/UBPy-regulated sorting and the development of sperm acrosome: the recruitment of MET. Reproduction (Cambridge, England). 149: 633-44.
PMID: # 25471559
Qiu, S. et al. 2014. MET receptor tyrosine kinase controls dendritic complexity, spine morphogenesis, and glutamatergic synapse maturation in the hippocampus. The Journal of neuroscience : the official journal of the Society for Neuroscience. 34: 16166-79.
PMID: # 26767046
Chang, H. et al. 2014. Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors. Thoracic cancer. 5: 517-24.
PMID: # 24589856
Ekman, M. et al. 2014. HIF-mediated metabolic switching in bladder outlet obstruction mitigates the relaxing effect of mitochondrial inhibition. Laboratory investigation; a journal of technical methods and pathology. 94: 557-68.
PMID: # 23715119
Zhou, D. et al. 2013. Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury. Kidney Int.. 84: 509-20.
PMID: # 23648337
Salian-Mehta, S. et al. 2013. AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival. Molecular and cellular endocrinology. 374: 92-100.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2017 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.